KATHERINE SOINE: Open Payments
NPI 1255096343 · PONTE VEDRA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,126 in 160 payments from 14 companies in 2025. Trend: 2023 $1,901 · 2024 $2,990 · 2025 $3,126
Food & beverage: $3,026Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 41 | $597 |
| Otsuka America Pharmaceutical, Inc. | 20 | $387 |
| Vanda Pharmaceuticals Inc. | 18 | $368 |
| Neurocrine BioSciences, Inc. | 15 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $258 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $230 |
| Lundbeck LLC | 8 | $197 |
| Alkermes, Inc. | 8 | $195 |
| Axsome Therapeutics, Inc. | 8 | $176 |
| Janssen Pharmaceuticals, Inc | 8 | $147 |
Products named: AUSTEDO XR, FANAPT, REXULTI, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, TRINTELLIX, ARISTADA.
Industry payments across FL — which companies pay providers there.
